Mingzhi Long

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Efficacy and Safety of SPH3127 Tablet, a Novel Direct Renin Inhibitor, in Patients with Mild-to-Moderate Essential Hypertension: A Phase III Randomised Trial.

Efficacy and Safety of SPH3127 Tablet, a Novel Direct Renin Inhibitor, in Patients with Mild-to-Moderate Essential Hypertension: A Phase III Randomised Trial.

Journal: Drugs

Published: December 24, 2025

Efficacy and safety of highly purified ethyl icosapentate soft capsules (MND-21) for the treatment of severe hypertriglyceridemia: A 12-week, multi-center, placebo-controlled, randomized, double-blind, phase III clinical trial in China.

Efficacy and safety of highly purified ethyl icosapentate soft capsules (MND-21) for the treatment of severe hypertriglyceridemia: A 12-week, multi-center, placebo-controlled, randomized, double-blind, phase III clinical trial in China.

Journal: Journal of clinical lipidology

Published: June 30, 2025

Cardiac myosin-binding protein-C levels are associated with severity and prognosis in stable coronary artery disease.

Cardiac myosin-binding protein-C levels are associated with severity and prognosis in stable coronary artery disease.

Journal: Scientific reports

Published: March 23, 2025

Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry.

Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry.

Journal: Scientific reports

Published: October 18, 2023

Management of nocturnal hypertension: An expert consensus document from Chinese Hypertension League.

Management of nocturnal hypertension: An expert consensus document from Chinese Hypertension League.

Journal: Journal of clinical hypertension (Greenwich, Conn.)

Published: July 20, 2023

WITHDRAWN: Long Non-coding RNA XIST Impedes LPS-induced AC16 Cell Inflammation and Apoptosis through Down-regulating miR-370-3p and Regulating PI3K/AKT/mTOR Pathways

WITHDRAWN: Long Non-coding RNA XIST Impedes LPS-induced AC16 Cell Inflammation and Apoptosis through Down-regulating miR-370-3p and Regulating PI3K/AKT/mTOR Pathways

Journal: Combinatorial chemistry & high throughput screening

Published: July 07, 2022

A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension.

A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension.

Journal: Medicine

Published: August 10, 2020

The effects of additional ezetimibe treatment to baseline rosuvastatin on circulating PCSK9 among patients with stable angina.

The effects of additional ezetimibe treatment to baseline rosuvastatin on circulating PCSK9 among patients with stable angina.

Journal: Journal of thoracic disease

Published: June 16, 2017

Curcumin activates autophagy and attenuates oxidative damage in EA.hy926 cells via the Akt/mTOR pathway.

Curcumin activates autophagy and attenuates oxidative damage in EA.hy926 cells via the Akt/mTOR pathway.

Journal: Molecular medicine reports

Published: January 20, 2015

Sodium tanshinone IIA silate as an add-on therapy in patients with unstable angina pectoris.

Sodium tanshinone IIA silate as an add-on therapy in patients with unstable angina pectoris.

Journal: Journal of thoracic disease

Published: October 20, 2014

Clinical study on effect of Shenmai Injection in treating congestive heart failure

Clinical study on effect of Shenmai Injection in treating congestive heart failure

Journal: Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine

Published: December 12, 2003

Showing 1-11 of 11

Last Updated: 09/26/2026